Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$GILD COVID-19, the first and only drug approved for the disease in the United States.
We have NEVER made a successful vaccine for a coronavirus before. This is why it's so difficult https://abc.net.au/news/health/2020-04-17/coronavirus-vaccine-ian-frazer/12146616…
BY MT Newswires — 1:58 PM ET 10/26/2020
BioSig Technologies (BSGM) tumbled almost 40% after saying its ViralClear subsidiary was ending phase II testing of a combination of its merimepodib enzyme inhibitor and Gilead Science's (GILD) remdesivir anti-viral in adult patients with advanced COVID-19. The move follows a safety monitoring committee observing an imbalance in survival rates making unlikely the trial would meet its primary safety endpoints.
$GILD F.D.A. Approves Remdesivir as First Drug to Treat Covid-19
https://www.nytimes.com/2020/10/22/us/remdesivir-fda-approved.html
grabbed a few too. long. GLTA
Corruption in Latin America During COVID-19 Pandemic. "Mexico is no stranger to corruption-related risks. According to the Barometer, 34% of public service users have paid a bribe in Mexico, regionally second only to Venezuela. In 2019"
https://www.natlawreview.com/article/fcpa-risks-latin-america-during-covid-19-pandemic
Mexico will not follow FDA in approving Gilead's COVID-19 drug
BY Reuters
— 9:59 PM ET 10/23/2020
MEXICO CITY, Oct 23 (Reuters) - Mexico will not necessarily follow the U.S. Food and Drug Administration (FDA) in approving Gilead Science Inc's antiviral drug remdesivir for use in COVID-19 patients, a top Mexican health official said on Friday.
Mexico's health regulator Cofepris has already twice denied approval for the drug with a "non-favorable" opinion, deputy health minister Hugo Lopez-Gatell told his regular nightly news conference.
"We have no mandate from the FDA," he said. "Cofepris has identified that the evidence does not suggest a usefulness, a sufficient efficacy."
The FDA approved remdesivir on Thursday, making it the first and only drug approved for the disease in the United States.
Remdesivir, given intravenously, was one of the drugs used to treat U.S. President Donald Trump during his bout with COVID-19.
The World Health Organization's (WHO) Solidarity trial last week concluded remdesivir has little or no impact on a patient's chances of surviving COVID-19, and a top WHO scientist on Friday recommended the FDA consider all available evidence. (Reporting by Sharay Angulo and Daina Beth Solomon Editing by Sonya Hepinstall)
Nice support here
grabbed a few here
$59.50...hmmm tempting level here
GILD is going to move higher later when Remdesivir sales will start
IMO this stock is going to skyrocket. I base this on the cost of the drug, and the demand. This drug shortens the time exposed to the symptoms. That means all vaccines will accompany this drug. Also many will not take the vaccine until they feel it is safe to do so. As time goes on some may get it more than once. This is not going away anytime soon, and the costs versus cost to make is huge. Why short for small possible gains. Hold long and reap rewards along with dividends.
Gilead Sciences Inc (GILD)
60.56 ? -0.11 (-0.18%)
Volume: 30,965,444 @10/23/20 7:59:55 PM EDT
Bid Ask Day's Range
57.58 68.0 60.76 - 63.64
GILD Detailed Quote
LOL yep wether you're Bearish or Bullish. It's not a pinky influenced by an IHUB board. I'm Bullish here going neutral on everything before the 3rd. No matter who wins expect a sell off. Keep your powder dry for the bargains before the bounce
77% tutes ownership. We're Good
GILD float is bloated ! the only way to make money with it is to short it on every pop like that for a couple of points
$gild $60.56 v -0.11 (-0.18%)
Volume: 30,965,444 @10/23/20 7:59:55 PM EDT
Very excited for this company :)
$GILD NYU Langone Medical Center’s Dr. Qanta Ahmed just gave a 10 minute interview with Neil Cavuto on Fox. She explained in very simple, but explicit terms that Remdesivir is an extremely effective therapeutic for COVID-19. She also explained in the same manner how the FDA granted the full approval based on a GOLD STANDARD STUDY WITH PLACEBO and that no serious clinical physician would dispute the findings
We've never made a successful vaccine for a coronavirus before. This is why it's so difficult https://abc.net.au/news/health/2020-04-17/coronavirus-vaccine-ian-frazer/12146616
Doctor on FOX this morning explaining how the WHO study was Flawed and how Remdisiver does indeed shorten Hospital Stay by several days.
$GILD Coronavirus vaccine will not be a cure-all, virologist warns https://www.cnbc.com/2020/06/26/coronavirus-vaccine-will-not-be-a-cure-all-virologist-warns.html
Nice post! Check out this link from doctors in Texas!
https://www.google.com/amp/s/abc13.com/amp/fda-approved-remdesivir-houston-doctors-gileads-gild-stock/7258986/
-Doctors call remdesivir the "U-turn drug."
Quote from link above:
"I see the patients very sick in the hospital, heading to the ICU, requiring more oxygen, getting worse and when they give remdesivir, and there's a response, they U-turn. They U-turn from the ICU and begin improving," Ostrosky said.
$GILD Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company's products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency virus (HIV) infection; and Vosevi, Vemlidy, Epclusa, Harvoni, and Viread products for treating liver diseases. It also provides Yescarta, a chimeric antigen receptor T cell therapy for adult patients with relapsed or refractory large B-cell lymphoma; Zydelig, a kinase inhibitor; Letairis, an oral formulation of an endothelin receptor antagonist for pulmonary arterial hypertension; Ranexa, a tablet to treat chronic angina; and AmBisome, an antifungal agent to treat serious invasive fungal infections. In addition, the company offers its products under the name Cayston, Emtriva, Hepsera, Sovaldi, and Tybost. Further, it develops product candidates for the treatment of viral diseases, inflammatory and fibrotic diseases, and oncology. The company markets its products through its commercial teams; and in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaboration agreements with Bristol-Myers Squibb Company; Janssen Sciences Ireland UC; Japan Tobacco Inc.; Galapagos NV; Second Genome; Gadeta; Carna Biosciences Inc.; Nurix Therapeutics, Inc.; Humanigen, Inc.; Kiniksa Pharmaceuticals, Ltd.; Kyverna Therapeutics, Inc.; Glympse Bio, Inc.; Renown Institute for Health Innovation; Goldfinch Bio, Inc.; Insitro, Inc.; Novo Nordisk A/S; Yuhan Corporation; Kite Pharma, Inc.; oNKo-innate Pty. Ltd.; and Roche Holding AG. The company has partnership with Arcus Biosciences, Inc. to co-develop and co-commercialize next-generation cancer immunotherapies. Gilead Sciences, Inc. was founded in 1987 and is headquartered in Foster City, California.
Jim Cramer "When you have more COVID, you buy the COVID stocks," $GILD
$GILD Piper Sandler analyst Tyler Van Buren raised the firm's price target on Gilead Sciences (GILD) to $95 from $83 and keeps an Overweight rating on the shares. The analyst says that while Gilead paid an "aggressive premium" for Immunomedics (IMMU), he loves the asset and the company's foray into solid tumors. "This is exactly what we have been waiting for," Van Buren tells investors in a research note. The acquisition provides Gilead with the potential to become a solid tumor "powerhouse," which could complement its existing cell therapy and immuno-oncology efforts, says the analyst.
GILD treatment cost around 3000 $ per person ! it is not affordable for everyone and many insurers will not cover it !
GILD will go higher for sure but not on COVID treatment alone !
https://www.google.com/amp/s/www.thehindu.com/sci-tech/health/coronavirus-us-gives-full-approval-to-antiviral-remdesivir-to-treat-covid-19/article32924346.ece/amp/
Quote from article above:
Europe and other countries such as Canada also have granted temporary approval for the use of remdesivir.
So it looks like Canada is also on board with Gilead’s covid 19 treatment! I wonder if we get news of a signed deal with them for even a couple of million worth of doses like the European Union 1 billion dollar deal..
Found on this link:
https://www.google.com/amp/s/mobile.reuters.com/article/amp/idUSKBN26Y25K
-Other countries are soon to follow probably as soon as next week. Once FDA approval other countries usually follow as FDA is considered the “gold standard.”
-GILD
Quote:
FDA had also authorized the drug for pediatric COVID-19 patients who are 11 years old or younger and who have been hospitalized.
All the way at the bottom of the article.
https://www.marketwatch.com/story/gileads-stock-rises-as-fda-formally-approves-remdesivir-2020-10-22
-GILD
$GILD Covid19 Infections Global Map https://coronavirus.jhu.edu/map.html
Yahoo finance 1 Year Target on $GILD is $78.42
$GILD CLOSED GREEN. Healthy pullback from HIGH of MONTH earlier trading.
$GILD CLOSED GREEN. Healthy pullback from HIGH of MONTH earlier trading.
It wasnt shorted the entire market was down today. $SPY $QQQ $DIA
up she goes monday
Shorts got there 52 week low here. Next week should be better IMO
Heavily shorted today. Speculation Earnings won't be met. Though ZACKS sees a 3% above projected. Acquisitions can increase the Value. I think the Market hasn't got up to Speed here
When the company acquire another company for instance gild tookover immunomedic does that force gild pps to go down ?? Is that the reason why we see wat we saw today ?? Im not sure someone explain this concept to me i feel like this is the reason why we saw gild pps drop today there was no clear reason why it is at 60 rn on fda approval
When the company acquire another company for instance gild tookover immunomedic does that force gild pps to go down ?? Is that the reason why we see wat we saw today ?? Im not sure someone explain this concept to me
Thanks I need to buy more calls way long.
An Open Letter from Merdad Parsey, Chief Medical Officer, Gilead Sciences
https://stories.gilead.com/articles/open-letter-from-merdad-parsey
Followers
|
165
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
4873
|
Created
|
04/30/09
|
Type
|
Free
|
Moderators |
333 Lakeside Drive
Foster City, CA 94404
PER IHUB MGMT |
02-07-2021
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION
AUTHORS MAY HAVE BUYS OR SELLS WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |